Inaugural

GI Cancers

Focus Meeting 2025

calendar icon

Marina del Rey Marriott, 4100 Admiralty Way, Marina Del Rey, CA 90292

calendar icon

July 25 - 26, 2025

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the GI Cancers Focus Meeting 2025, to be held at on July 25 - 26, 2025.

Centered around the theme “Updating Knowledge & Clinical Practice in 2025” this meeting provides pivotal collaboration aimed at advancing GI Cancers research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of GI Cancers Focus Meeting 2025:

Headshot of Chair: Eileen M. O’Reilly, MD

Eileen M. O’Reilly, MD

Memorial Sloan Kettering Cancer Center, New York City, NY

Headshot of Chair: Tanios Bekaii-Saab, MD

Tanios Bekaii-Saab, MD

Mayo Clinic, Phoenix, AZ

Thanks to Our Supporters

Agenda & Faculty

July 25, 2025 | Day 1

08:00 AM
Registration Opens

Session I: Pancreas Cancer


Moderated by:

Headshot of Eileen M. O’Reilly, MD

Eileen M. O’Reilly, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
09:00 AM
First-line Chemotherapeutic Options in mPDAC
Headshot of Ignacio Garrido-Laguna, MD

Ignacio Garrido-Laguna, MD

School of Medicine, University of Utah, Salt Lake City, UT
09:20 AM
RAS Directed-Therapies in mPDAC
Headshot of Eric Collisson, MD

Eric Collisson, MD

MD Anderson Cancer Center, Houston, TX
09:40 AM
Targeted (Excluding RAS Directed) Therapies in mPDAC
Headshot of Michael Pishvaian, MD

Michael Pishvaian, MD

MD Anderson Cancer Center, Houston, TX
10:00 AM
Panel Discussion
10:30 AM
Coffee Break

Session II: Biliary Tract Cancers (BTC)


10:50 AM
Immunotherapy Options in Advanced BTC
Headshot of Mitesh Borad, MD

Mitesh Borad, MD

Mayo Clinic, Phoenix, AZ
11:10 AM
HER2 Targeted Therapies in Advanced BTC
Headshot of James Cleary, MD

James Cleary, MD

Dana-Farber Cancer Institute, Boston, MA
11:30 AM
Emerging Treatment landscape in Early-stage BTC
Headshot of Jennifer Knox, MD

Jennifer Knox, MD

MD Anderson Cancer Center, Houston, TX
11:50 AM
Panel Discussion
12:20 PM
Lunch Break + Faculty and Fellow Photo

Session III: Hepatocellular Cancer (HCC)


Moderated by:

Headshot of Ghassan Abou-Alfa, MD

Ghassan Abou-Alfa, MD

Memorial Sloan Kettering Cancer Center, New York, NY
01:10 PM
Navigating First-line Treatment Options in HCC
Headshot of Anthony El-Khoueiry, MD

Anthony El-Khoueiry, MD

MD Anderson Cancer Center, Houston, TX
01:30 PM
Second-line Options in HCC in the Era of Immunotherapy
Headshot of Richard Finn, MD

Richard Finn, MD

UCLA Health, Los Angeles, CA
01:50 PM
Integrating Systemic Therapy in Early-stage HCC
Headshot of Ghassan Abou-Alfa, MD

Ghassan Abou-Alfa, MD

Memorial Sloan Kettering Cancer Center, New York, NY
02:10 PM
Panel Discussion
02:40 PM
Independent Expert Discussion Supported by BMS
03:10 PM
Coffee Break

Session IV: Neuroendocrine Tumors (NET)


Moderated by:

Headshot of Thorvadur Halfdanerson, MD

Thorvadur Halfdanerson, MD

MD Anderson Cancer Center, Houston, TX
03:30 PM
The Role of Peptide Receptor Radionuclide Therapy (PRRT) in NET
Headshot of Thorvadur Halfdanerson, MD

Thorvadur Halfdanerson, MD

MD Anderson Cancer Center, Houston, TX
03:50 PM
The Role of TKIs in NET
Headshot of Jennifer Chan, MD

Jennifer Chan, MD

Dana-Farber Cancer Institute, Boston, MA
04:10 PM
Systemic Therapy Opportunities in Early-stage NET
Headshot of Mohamad Bassam Sonbol, MD

Mohamad Bassam Sonbol, MD

Mayo Clinic, Phoenix, AZ
04:30 PM
Panel Discussion & Take-home Points from Day 1
05:00 PM
Adjourn

July 26, 2025 | Day 2

08:00 AM
Registration Opens

Session V: Esophagogastric Cancer (EGC)


Moderated by:

Headshot of Yelena Janjigian, MD

Yelena Janjigian, MD

MD Anderson Cancer Center, Houston, TX
09:00 AM
Immunotherapy Options in Advanced EGC
Headshot of Manish Shah, MD

Manish Shah, MD

Weill Cornell Medicine, New York, NY
09:20 AM
Emerging Targeted Options in advanced EGC
Headshot of Mohamad Bassam Sonbol, MD

Mohamad Bassam Sonbol, MD

Mayo Clinic, Phoenix, AZ
09:40 AM
Systemic Therapy options in early stage EGC
Headshot of Kelsey Klute, MD

Kelsey Klute, MD

University of Nebraska Medical Center, Omaha, NE
10:00 AM
Panel Discussion
10:30 AM
Coffee Break

Session VI: Metastatic Colorectal Cancer (mCRC)


Moderated by:

Headshot of Tanios Bekaii-Saab, MD

Tanios Bekaii-Saab, MD

Mayo Clinic, Phoenix, AZ
10:50 AM
Targeting HER2 in mCRC
Headshot of Kanwal P.S. Raghav, MD

Kanwal P.S. Raghav, MD

MD Anderson Cancer Center, Houston, TX
11:10 AM
Targeting RAS/RAF in mCRC
Headshot of Scott Kopetz, MD

Scott Kopetz, MD

MD Anderson Cancer Center, Houston, TX
11:30 AM
The potential for Immunotherapy in MSS mCRC
Headshot of Kristen Ciombor, MD

Kristen Ciombor, MD

MD Anderson Cancer Center, Houston, TX
11:50 AM
Panel Discussion
12:20 PM
Lunch Break

Session VII: Early-Stage and Oligometastatic CRC


Moderated by:

Headshot of Andrea Cercek, MD

Andrea Cercek, MD

MD Anderson Cancer Center, Houston, TX
01:10 PM
MSI-H CRC and Emerging Immunotherapy Options
Headshot of Tanios Bekaii-Saab, MD

Tanios Bekaii-Saab, MD

Mayo Clinic, Phoenix, AZ
01:30 PM
Moving Away from Trimodality Therapy for MSS Rectal Cancer
Headshot of Cathy Eng, MD

Cathy Eng, MD

01:50 PM
Emerging Modalities in the Treatment of Oligometastatic CRC
Headshot of Michael Overman, MD

Michael Overman, MD

MD Anderson Cancer Center, Houston, TX
02:10 PM
Panel Discussion
02:40 PM
Coffee Break

Session VIII: Molecular Residual Disease (MRD) and Liquid Biopsy Assessment in CRC and Other GI Malignancies


Moderated by:

Headshot of Christopher Lieu, MD

Christopher Lieu, MD

MD Anderson Cancer Center, Houston, TX
03:00 PM
A Predictive Role for MRD in Early-stage CRC
Headshot of Christopher Lieu, MD

Christopher Lieu, MD

MD Anderson Cancer Center, Houston, TX
03:20 PM
MRD as a Tool to Monitor Response in GI Malignancies
Headshot of Bassel El-Rayes, MD

Bassel El-Rayes, MD

MD Anderson Cancer Center, Houston, TX
03:40 PM
The Role of “Liquid Biopsies” in GI Malignancies – When & Why?
Headshot of Daniel H. Ahn, MD

Daniel H. Ahn, MD

Mayo Clinic, Phoenix, AZ
04:00 PM
Panel Discussion & Take-home Points from Day 2
04:30 PM
Adjourn

Alex Worthington

Project Manager

How long has Alex Worthington been in the business?

Alex Worthington has been with MD Education since 2024

About Alex Worthington

As Assistant Project Manager, I work to ensure the Smooth running of events, assisting in the search process, outreach, organization, and the maintenance of any event. Having a Diverse Career background Working around the world, I pride myself on networking and creating positive relationships seamlessly with all attendees.